This is not the most recent version of the article. View current version (8 DEC 2015)

Intervention Protocol

Amiodarone versus other pharmacological interventions for prevention of sudden cardiac death

  1. Juan Carlos Claro1,*,
  2. Roberto Candia1,
  3. Gabriel Rada1,
  4. Francisco Larrondo2,
  5. Fernando Baraona3,
  6. Luz M Letelier1

Editorial Group: Cochrane Heart Group

Published Online: 7 OCT 2009

DOI: 10.1002/14651858.CD008093


How to Cite

Claro JC, Candia R, Rada G, Larrondo F, Baraona F, Letelier LM. Amiodarone versus other pharmacological interventions for prevention of sudden cardiac death (Protocol). Cochrane Database of Systematic Reviews 2009, Issue 4. Art. No.: CD008093. DOI: 10.1002/14651858.CD008093.

Author Information

  1. 1

    Faculty of Medicine, Pontificia Universidad Católica de Chile, Department of Internal Medicine, Evidence Based Health Care Program, Santiago, Region Metropolitana, Chile

  2. 2

    Edificio Clinico, 5th floor, Clinica Alemana, Department of Intensive Care Medicine, Vitacura, Region Metropolitana, Chile

  3. 3

    Faculty of Medicine, Pontificia Universidad Católica de Chile, Department of Cardiovascular Diseases, Santiago, Region Metropolitana, Chile

*Juan Carlos Claro, Department of Internal Medicine, Evidence Based Health Care Program, Faculty of Medicine, Pontificia Universidad Católica de Chile, Lira 63, Santiago, Region Metropolitana, Chile. xuanca@gmail.com.

Publication History

  1. Publication Status: New
  2. Published Online: 7 OCT 2009

SEARCH

This is not the most recent version of the article. View current version (08 DEC 2015)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To evaluate the effectiveness of amiodarone as primary or secondary prevention in sudden cardiac death (SCD) compared with placebo or any other antiarrythmics in patients with high risk for sudden cardiac death, or who have recovered from a cardiac arrest or a syncope due to VT/VF. We aim to conduct a subgroup analysis for patients with or without ICD.